New Industry Ventures
VC Fund
Novosibirsk, Russian Federation
New Industry Ventures is a VC fund in Novosibirsk focused on Energy and Medical. New Industry Ventures was established by Gazprom Neft, Gazprombank, Russian Venture Company (RVC) and VEB Innovations. The Fund focuses on investments in technology companies specializing in the development of new materials, technologies, products and services for the oil and gas industry, petrochemical and energy industry, including alternativeenergy sources.New Industry was set up to spur the promotion of high-tech products in the Russian market and support innovative companies and start-ups that are important for the development of the oil and gas industry, the fuel and energy sector and the Russian industry. The priorities of the Fund are the development of technologies for the exploration, production, processing, transportation, distribution, use of hydrocarbons, energy transmission and storage, implementation of innovative solutions in the construction of industrial infrastructure, management of large-scale projects, etc. The investments also focus on resource and energy saving technologies, digital products, including 4.0. industry technology.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries New Industry Ventures invests in
Stages New Industry Ventures invests in
Countries New Industry Ventures invests in
Round sizes
Round size
- Seed
- $500k–$15M
- Series A
- $2.5M–$15M
Investment Focus
Industry
- Energy 2 (29%)
- Medical 2 (29%)
- Software 2 (29%)
- Pharmaceutical 2 (29%)
- Software Engineering 2 (29%)
Stage
- Seed 4 (57%)
- Series A 2 (29%)
- Funding Round 1 (14%)
Country
- Russian Federation 4 (57%)
- China 2 (29%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bioantibody
|
Bioantibody is a high-tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. | $14.8M / Series A / Jan 12, 2023 | |
META Pharmaceuticals
|
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases. | $15M / Seed / Jun 13, 2022 | |
NVI Solutions
|
An IT company specializing in the development and implementation of software products based on artificial intelligence for industrial customers, as well as adapting them to specific production tasks and implementing them at real production facilities in Russia and abroad.Today, the company's solutions are used by leading production sites,banks, oil producing companies, large IT integrators. | Seed / Feb 02, 2021 | |
Skyeer
|
Skyeer provides an analytics platform based on survey data from unmanned aerial vehicles, working, and design documentation in 2D/3D formats. They offer remote monitoring software for construction sites, quarries, and solid waste landfills using UAVs. It works on the DaaS model, providing data collection services using drones with theirsubsequent turnkey analysis. It helps to track the progress of work and manage the facility remotely. | $500K / Seed / Jan 15, 2021 | |
L-Petro
|
We develop, engineer, and manufacture oil well tractors that are used in highly extended reach wells. Our well tractors are combined with Coiled-Tubing ("CT") and Wireline ("WL") conveyance to offer a significant improvement in well accessibility for all types of openhole horizontal wells by providing extra pulling force topull CT and WL all the way to target depth. | $2.5M / Series A / Sep 30, 2020 | |
ML One
|
The solutions offered by ML One will allow producing from all sidetracks of a multilateral well and enable precise re-entry into the mainbore and laterals during production. We offer solutions suitable for new wells and existing multilateral wells with casing strings of any size. | $1.6M / Jan 29, 2020 | |
|
ML One
|
The solutions offered by ML One will allow producing from all sidetracks of a multilateral well and enable precise re-entry into the mainbore and laterals during production. We offer solutions suitable for new wells and existing multilateral wells with casing strings of any size. | $1.6M / Seed / Jan 29, 2020 |
Co-Investors
Phystech Ventures
2 deals together
Bondshine Capital
1 deal together
Dinghang Capital
1 deal together
Fang Fund Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does New Industry Ventures invest in?
New Industry Ventures invests primarily in Energy, Medical and Software startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Russian Federation. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is New Industry Ventures's check size?
New Industry Ventures typically joins rounds of $500k–$15M at Seed and $2.5M–$15M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds New Industry Ventures participates in.
When did New Industry Ventures last invest?
The most recent investment recorded for New Industry Ventures closed in Jan 2023. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
